NDAQ Stock Recent News
NDAQ LATEST HEADLINES
NEW YORK, July 18, 2025 (GLOBE NEWSWIRE) -- Today, Nasdaq issued the following statement on the preliminary proxy filed by Invesco QQQ Trust and the proposals contained within it.
Nasdaq (NDAQ) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Though volatility is inherent in Wall Street, some years are more of a roller-coaster ride than others.
Nvidia eyes a fresh record close on plans to resume AI chips sales in China. Inflation ticks higher in June with CPI rising 2.7% on an annual basis.
U.S. stocks traded mixed midway through trading, with the Nasdaq gaining more than 100 points on Tuesday.
We get started with a new CPI report and Q2 earnings results on Tuesday ahead of the open.
BALA CYNWYD, Pa., July 14, 2025 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.
NEW YORK, July 11, 2025 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common stock and warrants of NKGen Biotech, Inc. NKGen Biotech, Inc.'s securities were suspended on March 5, 2025 and have not traded on Nasdaq since that time.
Nasdaq is set to grow on its increasing on-trading revenue base, impressive organic growth and investments in proprietary data, supported by a solid capital position.
I'm reaffirming my prior buy rating on Nasdaq from summer 2023, seeing continued longer-term upside potential in this firm. Despite a share price topping its 5-year high, further investor bullishness can come from strong profit margins, top-line growth factors, and a sector getting tailwind from trading volume and volatility. Dividend investors will like the proven dividend growth and strong operating cash flow to support it.